Release Date: 30/07/15 08:22 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 210.22KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%